Sleep Architecture as a Digital Biomarker for Postpartum Depression in Hong Kong Mothers

Starting soon

Conditions studied: Postpartum Women

In brief

The goal of this study is to develop a postpartum depression (PND) Risk index using the UK Biobank dataset, and to validate the risk index in Hong Kong postpartum women. Participating Hong Kong postpartum women will wear an actigraphy (GENEActive) for 14 consecutive days.

Key facts

Study ID

NCT07600593

Run by

The University of Hong Kong

People needed

60

Starts

2026-07-01

Expected to finish

2028-01-31

Last updated by the study team

2026-05-20

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Mothers who are at least 18 years of age and are within 6 months of giving birth.
• Participants must be capable of reading Traditional Chinese, Mandarin, or English, to ensure they can provide informed consent and complete the required study documentation.

You may not qualify if…

• Individuals with specific conditions that might interfere with the measurement of sleep patterns related to mood will be excluded. This includes mothers diagnosed with sleep apnea or those who use CPAP machines.
• To reduce physiological noise in the data, women working permanent night shifts or those with severe medical complications, such as pre-eclampsia requiring ongoing medication, will also be excluded

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.